These data showing the better cancer-killing efficacy through AMPK activation support our present results that AMPK activation induced by 6-shogaol could attenuate the SREBP-1 expression and hence enhance the 5-FU-induced cytotoxicity of ACM-treated CRC cells. The gene discussed is SREBF1; the disease is cancer.